MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early‐onset cases

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Human Mutation

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/humu.20723PMID 18431737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer

  2007cited by this paper
• Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.

  2007influential reference
• A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.

  2007cited by this paper
• A novel RUNX2 missense mutation predicted to disrupt DNA binding causes cleidocranial dysplasia in a large Chinese family with hyperplastic nails

  2007cited by this paper
• A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

  2007cited by this paper
• Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer

  2007cited by this paper
• Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families

  2007cited by this paper
• Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.

  2006cited by this paper
• Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

  2006influential reference
• Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.

  2006influential reference
• Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer.

  2006cited by this paper
• Search for large genomic alterations of the BRCA1 gene in a Finnish population.

  2005cited by this paper
• Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

  2005cited by this paper
• Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families

  2005cited by this paper
• Genomic rearrangements in the BRCA1 and BRCA2 genes

  2005cited by this paper
• Large BRCA1 gene deletions are found in 3% of German high‐risk breast cancer families

  2004influential reference
• Significant Contribution of Germline BRCA2 Rearrangements in Male Breast Cancer Families

  2004cited by this paper
• Limited relevance of the CHEK2 gene in hereditary breast cancer

  2004cited by this paper
• CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

  2004cited by this paper
• Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi‐quantitative multiplex PCR method

  2003cited by this paper
• Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

  2003cited by this paper
• Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.

  2003influential reference
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families

  2002cited by this paper
• Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

  2002cited by this paper
• Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

  2002cited by this paper
• The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.

  2002cited by this paper
• Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

  2002cited by this paper
• Identification of a large rearrangement of theBRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing

  2001cited by this paper
• Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.

  2001cited by this paper
• The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

  2000cited by this paper
• Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.

  1999cited by this paper
• Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families

  1999influential reference
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997influential reference
• Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.

  1997cited by this paper
• Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.

  1996influential reference

• Characterization of Large Genomic Rearrangements in BRCA1 and BRCA2 Genes in a Chinese High-Risk Cohort.

  2026cites this paper
• Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population

  2024cites this paper
• Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with breast cancer

  2023cites this paper
• BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer

  2022cites this paper
• Decoding Breast Cancer Metabolism: Hunting BRCA Mutations by Raman Spectroscopy

  2022cites this paper
• Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme

  2022cites this paper
• The application of Raman spectroscopy and chemometric methods for analysis healthy blood and blood with BRCA mutation

  2022cites this paper
• BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies

  2022cites this paper
• 5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints

  2021cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2

  2021cites this paper
• Germline Structural Variations in Cancer Predisposition Genes

  2021influential citation
• iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression

  2021cites this paper
• Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center

  2020cites this paper
• The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer

  2020cites this paper
• Detection of BRCA1/2 Large Genomic Rearrangement including BRCA1 Promoter-Region Deletions using Next-Generation Sequencing.

  2020cites this paper
• Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients

  2020cites this paper
• Generalized Additive Models for the Detection of Copy Number Variations (CNVs) Using Multi-gene Panel Sequencing Data

  2020cites this paper
• From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high‐throughput sequencing

  2019cites this paper
• Detection of BRCA1/2 large genomic rearrangements in breast and ovarian cancer patients: an overview of the current methods

  2019cites this paper
• BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling

  2019cites this paper
• BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report

  2019cites this paper
• BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea

  2018cites this paper
• Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple‐negative or familial breast cancer

  2018cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India

  2018cites this paper
• Prevalence of BRCA 1 / 2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer Running title : BRCA 1 / 2 large genomic rearrangements in Chinese women with breast cancer

  2018cites this paper
• Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene.

  2017cites this paper
• Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.

  2017cites this paper
• Identification of large genomic rearrangement of BRCA1/2 in high risk patients in Korea

  2017cites this paper
• Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study

  2017cites this paper
• Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation

  2017cites this paper
• Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.

  2017cites this paper
• Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH

  2016cites this paper
• Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan

  2016influential citation
• Genomic rearrangement screening of the BRCA1 from seventy Iranian high-risk breast cancer families

  2016cites this paper
• Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review

  2015cites this paper
• Prevalence and differentiation of hereditary breast and ovarian cancers in Japan

  2015cites this paper
• Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features

  2015cites this paper
• Occurrence of a non deleterious gene conversion event in the BRCA1 gene

  2015cites this paper
• Large Genomic Rearrangements of BRCA1 and BRCA2 among Patients Referred for Genetic Analysis in Galicia (NW Spain): Delimitation and Mechanism of Three Novel BRCA1 Rearrangements

  2014cites this paper
• BRCA 1 and BRCA 2 germline mutations screening in Algerian breast / ovarian cancer families

  2014cites this paper
• Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea

  2014cites this paper
• The contribution of genetic susceptibility to breast cancer

  2014cites this paper
• First recurrent large genomic rearrangement in the BRCA1 gene found in Poland.

  2014cites this paper
• Screening for BRCA1 large genomic rearrangements in female Egyptian hereditary breast cancer patients.

  2013cites this paper
• A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer

  2013cites this paper
• The deletion of exons 3–5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families

  2013cites this paper
• The impact of genomics on oncology nursing.

  2013cites this paper
• Functional analysis-make or break for cancer predictability.

  2013cites this paper
• Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects

  2013cites this paper
• Klinik und Genetik des familiären Brust- und Eierstockkrebses

  2013cites this paper
• A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2

  2012cites this paper
• Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review

  2012cites this paper
• Identifying Susceptibility Genes for Familial Pancreatic Cancer Using Novel High-Resolution Genome Interrogation Platforms

  2012cites this paper
• Identification of germline genomic copy number variation in familial pancreatic cancer

  2012cites this paper
• Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms

  2012cites this paper
• Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics

  2012cites this paper
• Genomic characterization of two large Alu-mediated rearrangements of the BRCA1 gene

  2012cites this paper
• EMMA, a cost‐ and time‐effective diagnostic method for simultaneous detection of point mutations and large‐scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients

  2011cites this paper
• Identification of a new complex rearrangement affecting exon 20 of BRCA1

  2011cites this paper
• Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families

  2011cites this paper
• Extending the scope of diagnostic chromosome analysis: Detection of single gene defects using high‐resolution SNP microarrays

  2011cites this paper
• Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer.

  2011cites this paper
• Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia

  2011cites this paper
• Determinação de mutações e polimorfismo nos genes BRCA1 e BRCA2 em pacientes com câncer de mama com indicação para teste genético

  2011cites this paper
• Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.

  2011cites this paper
• PEDIGREE ANALYSIS OF PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS REVEALS GERM-LINE MUTATIONS IN THE DNA DAMAGE RESPONSE GENES BRCA1, BARD1 AND TP53

  2011cites this paper
• Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation

  2010influential citation
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cites this paper
• Identification of PKHD1 Multiexon Deletions Using Multiplex Ligation-Dependent Probe Amplification and Quantitative Polymerase Chain Reaction

  2010cites this paper
• A BRCA1 promoter variant (rs11655505) and breast cancer risk

  2010cites this paper
• Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients.

  2010cites this paper
• Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome‐like phenotype

  2010cites this paper
• Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations

  2010cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010influential citation
• BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families

  2010cites this paper
• CHARLES UNIVERSITY IN PRAGUE

  2010cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Low‐risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients

  2010cites this paper
• Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families

  2010cites this paper
• Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene

  2010cites this paper
• Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes

  2010cites this paper
• Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population

  2010cites this paper
• The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer

  2009cites this paper
• Deletion of Exons 1a-2 of BRCA1: A Rather Frequent Pathogenic Abnormality

  2009cites this paper
• Chromosome copy number variation and breast cancer risk

  2009cites this paper
• Accounting for uncertainty when assessing association between copy number and disease: a latent class model

  2009cites this paper
• Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

  2009cites this paper
• Hereditary breast cancer: from bench to bedside

  2008cites this paper